When business leader Laurie Cox AO ran out of options to treat his advanced prostate cancer, fortune smiled on him. He was offered an experimental treatment that became life-extending.
That was four years ago, and this nuclear treatment is now changing the way metastatic prostate cancer is managed. Although it worked beautifully for him, not all men who need it can get it.
Jill MargoSenior writerJill Margo is based in the Sydney office. Jill has won multiple prizes, including two Walkley Awards and is an adjunct associate professor at School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Australia. Connect with Jill on Twitter. Email Jill at jmargo@afr.com
